Status:
RECRUITING
Systems Oncology Approach to Optimize Ovarian Cancer Treatment
Lead Sponsor:
University of Helsinki
Collaborating Sponsors:
Helsinki University Central Hospital
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
Brief Summary
The overall aim is to identify effective therapeutic strategies to ovarian cancer (OC) using serial tumor, ascites and blood samples, and carry out state-of-the-art sequencing approaches, functional a...
Eligibility Criteria
Inclusion
- Patients diagnosed with ovarian cancer
- Available tumor tissue/blood samples
Exclusion
- Inability to consent to the study
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06117384
Start Date
January 1 2022
End Date
December 31 2027
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helsinki University and Helsinki University Hospital
Helsinki, Finland, 00014